Tempus Labs had one patents in big data during Q4 2023. Tempus Labs Inc has developed a system for personalized depression disorder treatment, which includes a server, a database for storing patient outcomes, and a user device with a GUI. The analytics module analyzes patient data to determine personalized treatment options and predict depression states. GlobalData’s report on Tempus Labs gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Tempus Labs grant share with big data as a theme is 0% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Data-based mental disorder research and treatment systems and methods (Patent ID: US20230386643A1)
The patent filed by Tempus Labs Inc. discloses a system for personalized depression disorder treatment, involving a server, a database storing patient outcomes, and a user device with a GUI. The system utilizes an analytics module to determine personalized treatment or state predictions based on empirical patient outcomes and data. The method outlined in the claims involves obtaining molecular data from a patient sample, clinical data, and cohort data to generate a report from a therapy engine listing nucleic acid sequences associated with the disorder, effective drugs, and potential side effects. The system can be updated with subsequent clinical data to refine treatment recommendations and includes a knowledge database with drug interaction information.
The system and method described in the patent aim to provide personalized treatment information for patients diagnosed with mental health disorders, particularly depression. By analyzing molecular data, clinical history, and cohort data, the system generates reports listing effective drugs and potential side effects based on genetic information. The therapy engine includes a knowledge database with drug interaction details and can be updated with new clinical data to improve treatment recommendations over time. Overall, the patent outlines a comprehensive approach to personalized mental health treatment using genetic data and clinical information to optimize patient outcomes.
To know more about GlobalData’s detailed insights on Tempus Labs, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
